Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Update

by · The Markets Daily

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF – Get Free Report) saw a large decrease in short interest in the month of May. As of May 29th, there was short interest totaling 1,278,919 shares, a decrease of 37.0% from the May 14th total of 2,031,410 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Genomma Lab Internacional Stock Performance

Genomma Lab Internacional stock remained flat at $0.84 during trading hours on Tuesday. 9,000 shares of the company’s stock were exchanged, compared to its average volume of 1,800. Genomma Lab Internacional has a 52 week low of $0.84 and a 52 week high of $1.27. The business’s fifty day moving average price is $1.06 and its 200 day moving average price is $1.03.

Genomma Lab Internacional Company Profile

(Get Free Report)

Genomma Lab Internacional, SAB. de C.V. is a Mexico City–based consumer healthcare company that develops, markets and distributes over-the-counter (OTC) pharmaceuticals, personal care products and beauty solutions. Since its founding in 1996, the firm has built a diversified portfolio encompassing topical analgesics, cold and flu remedies, digestive health treatments, skin and hair care lines, and nutritional supplements. Its product mix blends proprietary brands with licensed formulas, targeting everyday wellness and self-care needs.

The company’s growth strategy hinges on intensive marketing campaigns, including television infomercials, digital advertising and direct‐to‐consumer promotions.

Featured Articles